UVA-induced effects of 2,6-disubstituted 4-anilinoquinazolines on cancer cell lines

Journal of Photochemistry and Photobiology B: Biology

Volumn 154, Issue , 2016, Pages 77-88

  Jantová, Soňa ^a   Melušová, Martina ^a   Pánik, Miroslav ^a   Brezová, Vlasta ^a   Barbieriková, Zuzana ^a  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

Author keywords

4 Anilinoquinazolines; Apoptosis; Cytotoxic phototoxic effects; EPR spectroscopy; Leukemia; Photoinduced processes; Spin trapping

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; ANTINEOPLASTIC AGENT; N,2 DIPHENYL QUINAZOLIN 4 AMINE; OXYGEN; QUINAZOLINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TEMPOL; UNCLASSIFIED DRUG; CASPASE 3; CASPASE 9; PHOTOSENSITIZING AGENT; SINGLET OXYGEN;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; ELECTRON SPIN RESONANCE; HELA CELL LINE; HT 29 CELL LINE; HUMAN; HUMAN CELL; IC50; L1210 CELL LINE; MOUSE; NONHUMAN; PHOTOACTIVATION; PHOTOOXIDATION; PHOTOTOXICITY; PRIORITY JOURNAL; SPIN TRAPPING; ULTRAVIOLET A RADIATION; ANIMAL; CELL PROLIFERATION; CHEMISTRY; COMET ASSAY; DRUG EFFECTS; HT-29 CELL LINE; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; RADIATION RESPONSE; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; COMET ASSAY; DNA DAMAGE; ELECTRON SPIN RESONANCE SPECTROSCOPY; HELA CELLS; HT29 CELLS; HUMANS; MICE; MITOCHONDRIA; OXIDATION-REDUCTION; PHOTOSENSITIZING AGENTS; QUINAZOLINES; SINGLET OXYGEN; SUPEROXIDES; ULTRAVIOLET RAYS;

EID: 84949603941     PISSN: 10111344     EISSN: 18732682     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2015.11.014     Document Type: Article

References (77)

1. I. Khan, A. Ibrar, W. Ahmed, and A. Saeed Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: the advances continue Eur. J. Med. Chem. 90 2015 124 169
2. J. Hu, Y. Zhang, L. Dong, Z. Wang, L. Chen, D. Liang, D. Shi, X. Shan, and G. Liang Design, synthesis, and biological evaluation of novel quinazoline derivatives as anti-inflammatory agents against lipopolysaccharide-induced acute lung injury in rats Chem. Biol. Drug Des. 85 2015 672 684
3. S. Jantová, L. Ružeková, Š. Stankovský, and K. Špirková Antiproliferation activity and the mechanism of action of 9-bromo-5-morpholino-tetrazolo[1,5-c]quinazoline - potentional anticancer drug Neoplasma 44 1997 240 246
4. G. Traquandi, M. Ciomei, D. Ballinari, E. Casale, N. Colombo, V. Croci, F. Fiorentini, A. Isacchi, A. Longo, C. Mercurio, A. Panzeri, W. Pastori, P. Pevarello, D. Volpi, P. Roussel, A. Vulpetti, and M.G. Brasca Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitor J. Med. Chem. 53 2010 2171 2187
5. S. Jantová, M. Urbančíková, T. Maliar, M. Mikulášová, P. Rauko, ̗. Čipák, J. Kubíková, Š. Stankovský, and K. Špirková Biological activity of some 4-anilinoquinazolines: cytotoxic, genotoxic and antiprotease effects, induction of necrosis and changes of actin cytoskeleton Neoplasma 48 2001 52 60
6. V. Spanò, A. Montalbano, A. Carbone, B. Parrino, P. Diana, G. Cirrincione, I. Castagliuolo, P. Brun, O.G. Issinger, S. Tisi, I. Primac, D. Vedaldi, A. Salvador, and P. Barraja Synthesis of a new class of pyrrolo[3,4-h]quinazolines with antimitotic activity Eur. J. Med. Chem. 74 2014 340 357
7. M.U. Rahman, A. Rathore, A.A. Siddiqui, G. Parveen, and M.S. Yar Synthesis and characterization of quinazoline derivatives: search for hybrid molecule as diuretic and antihypertensive agents J. Enzyme Inhib. Med. Chem. 29 2014 733 743
8. F. Casuscelli, A. Ermoli, D. Faiardi, and C. Piutti Substituted pyrazolo-quinazoline derivatives as kinase inhibitors Nerviano Medical Sciences S.R.L. 2012 PCT/IB2011/055743, WO2012080990 A1
9. S. Jantová, S. Letašiová, R. Ovádeková, and M. Múčková Cytotoxic/antiproliferative effects of new [1,2,4]triazolo[4,3-c] quinazolines in tumor cell lines HeLa and B16 Neoplasma 53 2006 291 300
10. S. Jantová, Š. Baláž, Š. Stankovský, K. Špirková, and V. Lukáčová Relationships between the structure, cytotoxicity and hydrophobicity of quinazoline derivatives by quantitative structure-activity relationship Folia Biol. 43 1997 83 89 Prague, Czech Repub.
11. S. Jantová, Š. Stankovský, and K. Špirková In vitro antibacterial activity of ten series of substituted quinazolines Biologia - Sect. Cell. Mol. Biol. 59 2004 741 752
12. M. Asif Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivatives Int. J. Med. Chem. 2014 2014 395637
13. S. Ravez, O. Castillo-Aguilera, P. Depreux, and L. Goossens Quinazoline derivatives as anticancer drugs: a patent review (2011-present) Expert Opin. Ther. Pat. 25 2015 789 804
14. M. Hazarika, R.M. White Jr., B.P. Booth, Y.C. Wang, D.Y. Lee Ham, Y.L. Cheng, A. Rahman, J.V.S. Gobburu, N. Li, R. Sridhara, D.E. Morse, R. Lostritto, P. Garvey, J.R. Johnson, and R. Pazdur Pemetrexed in malignant pleural mesothelioma Clin. Cancer Res. 11 2005 982 992
15. M. Jhawer, L. Rosen, J. Dancey, H. Hochster, S. Hamburg, M. Tempero, N. Clendeninn, and S. Mani Phase II trial of nolatrexed dihydrochloride [Thymitaq™, AG 337] in patients with advanced hepatocellular carcinoma Investig. New Drugs 25 2007 85 94
16. Y. Liu, W. Wu, W. Hong, X. Sun, J. Wu, and Q. Huang Raltitrexed-based chemotherapy for advanced colorectal cancer Clin. Res. Hepatol. Gastroenterol. 38 2014 219 225
17. H.Y. Sun, S. Guan, H.C. Bi, Q.B. Su, W.L. Huang, B. Chowbay, M. Huang, X. Chen, C.G. Li, and S.F. Zhou Determination of CH330331, a novel 4-anilinoquinazoline inhibitor of epidermal growth factor receptor tyrosine kinase, in human Caco-2 monolayers by high performance liquid chromatography with ultraviolet detection: application to a trans-epithelial transport study J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 854 2007 320 327
18. K. Singh, P.P. Sharma, A. Kumar, A. Chaudhary, and R.K. Roy 4-Aminoquinazoline analogs: a novel class of anticancer agents Mini-Rev. Med. Chem. 13 2013 1177 1194
19. V. Chandregowda, A.K. Kush, and G. Chandrasekara Reddy Synthesis and in vitro antitumor activities of novel 4-anilinoquinazoline derivatives Eur. J. Med. Chem. 44 2009 3046 3055
20. S. Jantová, ̗ Čipák, D. Slameňová, V. Horváth, and P. Rauko Induction of cytotoxicity and ssDNA breaks by 9-bromo-5-morpholino-tetrazolo[1,5-c]quinazoline in tumor cells cultured in vitro Toxicol. in Vitro 17 2003 457 463
21. S. Jantová, S. Letašiová, A. Repický, R. Ovádeková, and B. Lakatoš The effect of 3-(5-nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4] triazolo[4,3-c]quinazoline on cell growth, cell cycle, induction of DNA fragmentation, and activity of caspase 3 in murine leukemia L1210 cells and fibroblast NIH-3 T3 cells Cell Biochem. Funct. 24 2006 519 530
22. S. Jantová, A. Repický, E. Paulovičová, S. Letašiová, and ̗. Čipák Antiproliferative activity and apoptosis induced by 6-bromo-2-(morpholin-1-yl)-4-anilinoquinazoline on cells of leukemia lines Exp. Oncol. 30 2008 139 142
23. Y.Y. Xu, S.N. Li, G.J. Yu, Q.H. Hu, and H.Q. Li Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity Bioorg. Med. Chem. 21 2013 6084 6091
24. X. Chen, Y. Du, H. Sun, F. Wang, L. Kong, and M. Sun Synthesis and biological evaluation of novel tricyclic oxazine and oxazepine fused quinazolines. Part 1: erlotinib analogs Bioorg. Med. Chem. Lett. 24 2014 884 887
25. Q. Zhang, Z. Wang, J. Guo, L. Liu, X. Han, M. Li, S. Fang, X. Bi, N. Tang, and Y. Liu Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer OncoTargets Ther. 8 2015 893 898
26. A.J. Colquhoun, L.A. McHugh, E. Tulchinsky, M. Kriajevska, and J.K. Mellon Combination treatment with ionising radiation and gefitinib ('iressa', ZD1839), an epidermal growth factor receptor (EGFR) inhibitor, significantly inhibits bladder cancer cell growth in vitro and in vivo J. Radiat. Res. 48 2007 351 360
27. J.L. Dominguez-Escrig, J.D. Kelly, D.E. Neal, S.M. King, and B.R. Davies Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer Clin. Cancer Res. 10 2004 4874 4884
28. S.B. Maddineni, V.K. Sangar, J.H. Hendry, G.P. Margison, and N.W. Clarke Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines Br. J. Cancer 92 2005 125 130
29. M. Niyazi, C. Maihoefer, M. Krause, C. Rödel, W. Budach, and C. Belka Radiotherapy and new drugs-new side effects? Radiat. Oncol. 6 2011 177
30. H. Fujita, and I. Matsuo Phototoxic potential of afloqualone, a quinazolinone derivative, as determined by photosensitized inactivation of bacteriophage Chem. Biol. Interact. 64 1987 139 149
31. K. Hayakawa, and I. Matsuo Afloqualone phototoxicity - photosensitized lipid peroxidative potency and its biological significance Tokai J. Exp. Clin. Med. 14 1989 15 24
32. Y. Tokura, M. Ogai, H. Yagi, and M. Takigawa Afloqualone photosensitivity: immunogenicity of afloqualone-photomodified epidermal cells Photochem. Photobiol. 60 1994 262 267
33. P. Barraja, L. Caracausi, P. Diana, A. Montalbano, A. Carbone, A. Salvador, P. Brun, I. Castagliuolo, S. Tisi, F. Dall'Acqua, D. Vedaldi, and G. Cirrincione Pyrrolo[3,2-h]quinazolines as photochemotherapeutic agents ChemMedChem 6 2011 1238 1248
34. G. Miolo, A. Salvador, A. Mazzoli, A. Spalletti, G. Marzaro, and A. Chilin Photochemical and photobiological studies on furoquinazolines as new psoralen analogs J. Photochem. Photobiol. B 138 2014 43 54
35. A. Salvador, D. Vedaldi, P. Brun, and S. Dall'Acqua Vandetanib-induced phototoxicity in human keratinocytes NCTC-2544 Toxicol. in Vitro 28 2014 803 811
36. V. Spanò, B. Parrino, A. Carbone, A. Montalbano, A. Salvador, P. Brun, D. Vedaldi, P. Diana, G. Cirrincione, and P. Barraja Pyrazolo[3,4-h]quinolines promising photosensitizing agents in the treatment of cancer Eur. J. Med. Chem. 102 2015 334 351
37. P. Barraja, P. Diana, A. Montalbano, A. Carbone, G. Viola, G. Basso, A. Salvador, D. Vedaldi, F. Dall'Acqua, and G. Cirrincione Pyrrolo[3,4-h]quinolinones a new class of photochemotherapeutic agents Bioorg. Med. Chem. 19 2011 2326 2341
38. C. Chignell, J. Haseman, R. Sik, R. Tennant, and C. Trempus Photocarcinogenesis in the Tg.AC mouse: lomefloxacin and 8-methoxypsoralen Photochem. Photobiol. 77 2003 77 80
39. J.N. Ribeiro, A.R. da Silva, and R.A. Jorge Involvement of mitochondria in apoptosis of cancer cells induced by photodynamic therapy J. Bras. Patol. Med. Lab. 40 2004 383 390
40. M. Wainwright Photodynamic antimicrobial chemotherapy (PACT) J. Antimicrob. Chemother. 42 1998 13 28
41. M. Wainwright Photodynamic therapy: the development of new photosensitisers Anti Cancer Agents Med. Chem. 8 2008 280 291
42. S. Gerchakov, and H.P. Schultz Quinoxaline studies. XIV. Potential anticancer agents. Some quinoxaline amino acid and dipeptide derivatives related to quinoxaline antibiotics J. Med. Chem. 12 1969 141 144
43. J.R. Rigas, W.P. Tong, M.G. Kris, J.P. Orazem, C.W. Young, and R.P. Warrell Jr. Phase I clinical and pharmacological study of chloroquinoxaline sulfonamide Cancer Res. 52 1992 6619 6623
44. B. Parrino, A. Carbone, C. Ciancimino, V. Spanò, A. Montalbano, P. Barraja, G. Cirrincione, P. Diana, C. Sissi, M. Palumbo, O. Pinato, M. Pennati, G. Beretta, M. Folini, P. Matyus, B. Balogh, and N. Zaffaroni Water-soluble isoindolo[2,1-a]quinoxalin-6-imines: in vitro antiproliferative activity and molecular mechanism(s) of action Eur. J. Med. Chem. 94 2015 149 162
45. B. Parrino, A. Carbone, V. Spanò, A. Montalbano, D. Giallombardo, P. Barraja, A. Attanzio, L. Tesoriere, C. Sissi, M. Palumbo, G. Cirrincione, and P. Diana Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity Eur. J. Med. Chem. 94 2015 367 377
46. Š. Stankovský, and D. Mrázová Preparation of substituted 2-phenyl-4-anilinoquinazolines through imidoylcarbodiimides Chem. Pap. 38 1983 549 555
47. Š. Stankovský, and A. Martvoň Synthesis of substituted 4-anilinoquinazolines Collect. Czechoslov. Chem. Commun. 61 1996 1681 1688
48. D.R. Duling Simulation of multiple isotropic spin-trap EPR Spectra J. Magn. Reson., Ser. B 104 1994 105 110
49. Z. Barbieriková, D. Dvoranová, M. Bella, V. Milata, A. Czímerová, and V. Brezová Fused-ring derivatives of quinoxalines: spectroscopic characterization and photoinduced processes investigated by EPR spin trapping technique Molecules 19 2014 12078 12098
50. Z. Barbieriková, M. Bella, J. Kučerák, V. Milata, S. Jantová, D. Dvoranová, M. Veselá, A. Staško, and V. Brezová Photoinduced superoxide radical anion and singlet oxygen generation in the presence of novel selenadiazoloquinolones (an EPR study) Photochem. Photobiol. 87 2011 32 44
51. Z. Barbieriková, A. Staško, J. Semanová, D. Dvoranová, M. Karabín, M. Bella, V. Milata, and V. Brezová Photoinduced processes of 2,1,3-benzoselena(thia)diazole derivatives in dimethylsulfoxide: an in situ EPR spin trapping study Monatsh. Chem. 145 2014 1449 1460
52. G.R. Buettner Spin trapping: ESR parameters of spin adducts Free Radic. Biol. Med. 3 1987 259 303
53. V. Brezová, S. Gabčová, D. Dvoranová, and A. Staško Reactive oxygen species produced upon photoexcitation of sunscreens containing titanium dioxide (an EPR study) J. Photochem. Photobiol. B 79 2005 121 134
54. R. Herscu-Kluska, A. Masarwa, M. Saphier, H. Cohen, and D. Meyerstein Mechanism of the reaction of radicals with peroxides and dimethyl sulfoxide in aqueous solution Chem. - Eur. J. 14 2008 5880 5889
55. H. Wu, Q. Song, G. Ran, X. Lu, and B. Xu Recent developments in the detection of singlet oxygen with molecular spectroscopic methods, TrAC Trends Anal. Chem. 30 2011 133 141
56. R. Albuschat, W. Löwe, M. Weber, P. Luger, and V. Jendrossek 4-Anilinoquinazolines with Lavendustin A subunit as inhibitors of epidermal growth factor receptor tyrosine kinase: syntheses, chemical and pharmacological properties Eur. J. Med. Chem. 39 2004 1001 1011
57. M.K. Nyati, D. Maheshwari, S. Hanasoge, A. Sreekumar, S.D. Rynkiewicz, A.M. Chinnaiyan, W.R. Leopold, S.P. Ethier, and T.S. Lawrence Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivo Clin. Cancer Res. 10 2004 691 700
58. G. Marzaro, A. Guiotto, and A. Chilin Quinazoline derivatives as potential anticancer agents: a patent review (2007-2010) Expert Opin. Ther. Pat. 22 2012 223 252
59. H. Shiheido, Y. Naito, H. Kimura, H. Genma, H. Takashima, M. Tokunaga, T. Ono, T. Hirano, W. Du, T. Yamada, N. Doi, S. Iijima, Y. Hattori, and H. Yanagawa An anilinoquinazoline derivative inhibits tumor growth through interaction with hCAP-G2, a subunit of condensin II PLoS One 7 2012 e44889
60. S. Mowafy, N. Farag, and K. Abouzid Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors Eur. J. Med. Chem. 61 2013 132 145
61. M. Sadek, R. Serrya, A. Kafafy, M. Ahmed, F. Wang, and K. Abouzid Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents J. Enzyme Inhib. Med. Chem. 29 2014 215 222
62. A. Alberti, and D. Macciantelli Spin Trapping M. Brustolon, E. Giamelo, Electron Paramagnetic Resonance: A Practitioner's Toolkit 2009 John Wiley & Sons Hoboken, New Jersey 287 323
63. -, electrochemically generated in DMSO at room temperature Electrochim. Acta 53 2008 3412 3415
64. K. Gollnick, and H.-U. Stracke Direct and sensitized photolysis of dimethyl sulphoxide in solution Pure Appl. Chem. 33 1973 217 246
65. D.T. Sawyer, and J.S. Valentine How super is superoxide? Acc. Chem. Res. 14 1981 393 400
66. B. Halliwell, and J. Gutteridge Free Radicals in Biology and Medicine third ed. 1999 Oxford University Press USA, Oxford
67. M. Tarr, and D. Valenzeno Singlet oxygen: the relevance of extracellular production mechanisms to oxidative stress in vivo Photochem. Photobiol. Sci. 2 2003 355 361
68. K. Nakamura, K. Ishiyama, H. Ikai, T. Kanno, K. Sasaki, Y. Niwano, and M. Kohno Reevaluation of analytical methods for photogenerated singlet oxygen J. Clin. Biochem. Nutr. 49 2011 87 95
69. Y. Lion, E. Gandin, and A. Van de Vorst On the production of nitroxide radicals by singlet oxygen reaction: an EPR study Photochem. Photobiol. 31 1980 305 309
70. Z. Barbieriková, M. Mihalíková, and V. Brezová Photoinduced oxidation of sterically hindered amines in acetonitrile solutions and titania suspensions (an EPR study) Photochem. Photobiol. 88 2012 1442 1454
71. A. Telliez, M. Desroses, N. Pommery, O. Briand, A. Farce, G. Laconde, A. Lemoine, P. Depreux, and J.P. Hénichart Derivatives of Iressa, a specific epidermal growth factor receptor inhibitor, are powerful apoptosis inducers in PC3 prostatic cancer cells ChemMedChem 2 2007 318 332
72. N. Sirisoma, S. Kasibhatla, A. Pervin, H. Zhang, S. Jiang, J.A. Willardsen, M.B. Anderson, V. Baichwal, G.G. Mather, K. Jessing, R. Hussain, K. Hoang, C.M. Pleiman, B. Tseng, J. Drewe, and X.C. Sui Discovery of 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a potent inducer of apoptosis with high in vivo activity J. Med. Chem. 51 2008 4771 4779
73. N. Sirisoma, A. Pervin, H. Zhang, S. Jiang, J.A. Willardsen, M.B. Anderson, G. Mather, C.M. Pleiman, S. Kasibhatla, B. Tseng, J. Drewe, and S.X. Cai Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration J. Med. Chem. 52 2009 2341 2351
74. M. Hopfner, A. Sutter, B. Gerst, M. Zeitz, and H. Scherubl A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839) Br. J. Cancer 89 2003 1766 1775
75. E. Lindhagen, A. Eriksson, M. Wickstrom, K. Danielsson, B. Grundmark, R. Henriksson, P. Nygren, A. Aleskog, R. Larsson, and M. Hoglund Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia Eur. J. Haematol. 81 2008 344 353
76. T.T. Chao, C.Y. Wang, Y.L. Chen, C.C. Lai, F.Y. Chang, Y.T. Tsai, C.H.H. Chao, C.W. Shiau, Y.C.T. Huang, C.J. Yu, and K.F. Chen Afatinib induces apoptosis in NSCLC without EGFR mutation through Elk-1-mediated suppression of CIP2A Oncotarget 6 2015 2164 2179
77. S. Jantová, K. Koňariková, S. Letašiová, E. Paulovičová, V. Milata, and V. Brezová Photochemical and phototoxic properties of ethyl 1,4-dihydro-8-nitro-4-oxoquinoline-3-carboxylate, a new quinoline derivative J. Photochem. Photobiol. B 102 2011 77 91